NEW YORK (GenomeWeb) – Nanion Technologies and Axion Biosystems today announced a distribution deal covering Europe and China.

Under the terms of the agreement, Nanion will immediately distribute, service, and support Axion's single-well microelectrode array system called the Muse, as well as the Maestro system, a multiwall MEA system with high-throughput screening capabilities. The deal comes amid growing demand for "disease-in-a-dish" assays and functional safety screening, the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.